Committed to advancing clinical research, from laboratory discovery through product approval

ICON’s Internal Medicine and Immunosciences division has established therapeutically-aligned Centers of Excellence to provide sponsors with guidance and insight from our therapeutic and clinical experts. Our team assists sponsors with evaluating and understanding the challenges encountered throughout the drug development life cycle and offers world-class strategies and solutions.

These Centers of Excellence draw upon extensive global nonclinical, clinical, regulatory and operational expertise to assist clients with successful trial delivery from IND preparation to product approval.  Additionally, the Centers of Excellence leverage many of the industry’s leading medical, regulatory and commercial experts as well as long-standing relationships with key opinion leaders, research sites and academic research centers.

ICON is experienced in successfully collaborating with sponsors ranging from small virtual startups to the largest global, integrated pharmaceutical companies.
 

ICON’s Internal Medicine and Immunosciences Centers of Excellence

ICON’s Internal Medicine and Immunosciences division has conducted the following in the last 5 years:

  • 53,000

    Patients
  • 12,500

    Sites
  • 210

    Studies

ICON’s Internal Medicine and Immunosciences Centers of Excellence have significant expertise in

 – Drug development and strategy consultation

 – Clinical development program planning

 – Individual study design

– Peri-IND activities / submissions

– Phase I - III study execution

– Global regulatory submissions

 – Product commercialization (valuation market analysis, positioning, launch, etc.)